Genmab — Juni 2016
-
JKY: Der er også noget fredag 16:50 til 17:00 af en græker:
(LB2238) AN OPEN-LABEL, RANDOMISED PHASE 3 STUDY OF DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE (DRD) VERSUS LENALIDOMIDE AND DEXAMETHASONE (RD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): POLLUX
Meletios A Dimopoulos (National and Kapodistrian University of Athens,Athens,Greece)
Friday 16:50 - 17:00 -
og søndag 12:00 til 12:15:
(LB2236) PHASE 3 RANDOMISED CONTROLLED STUDY OF DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: CASTOR
Sunday 12:00 - 12:15 -
Så POLLUX er fredag 16:50 til 17:00. Søndag er CASTOR
-
Det er ikke mange minutter der er til så vigtige data.
-
Så har ASCO lige uploaded et interview med Antonio Palumbo vedr. Castor https://www.youtube.com/watch?v=j3KjdMlOLrY
-
En fornøjelse at lytte til. Han og intervieweren er bare så glade over de fantastiske data.
-
-
Ses vi i morgen på Investordagen i Aarhus? Som bruger på Proinvestor.com får du gratis adgang. Bestil din VIP-billet på linket. Brug koden VIPPROINVESTOR. http://butik.shareholders.dk/events/1234-is/investordagen-i-aarhus-2016
-
Jeg er helt enig med Per her: http://play.borsen.dk/social/5755402d725ed7540a0d69a9
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind